Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib maintenance in uterine serous carcinoma
NCT04080284Phase 2Completed
- Sponsor
- Northwell Health
- Start
- Dec 2019
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in uterine serous carcinoma (USC), sponsored by Northwell Health. Started Dec 2019; status: completed.
02
Drugs
niraparib
03
Conditions
uterine serous carcinoma (USC)
Beyond the preview
Go deeper on NCT04080284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04080284.